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To the Editor: We have 2 concerns about the study by Ms van
Schoor and colleagues.1 First, many participants were lost to
follow-up, potentially creating differences between the inter-
vention and control groups that might have biased the results.
Second, many participants assigned to wear the hip protectors
stopped doing so during the trial. This dilution of the inter-
vention group with nonusers decreases the power of the study
to detect any possible benefit of hip protectors that were ac-
tually worn.
These problems could have been addressed by randomizing
hips rather than individuals. Each participant would be ran-
domly assigned to wear a single protector on either the right
or left side. This design would result in intervention and con-
trol hips that would be similar in regard to risk factors for a
hip fracture, such as bone strength or propensity for a fall.
When participants are lost to follow-up, both of their hips
would be lost, retaining the balance of fracture risk factors
that was achieved by the initial randomization. The results
using this design would be valid to the extent that a hip pro-
tector does not affect the side to which a person wearing one
might fall.
A matched trial can produce valid risk ratios for all matched
pairs by using information only from those pairs that have the
study outcome—a hip fracture.2-5 Therefore most follow-up
could be limited to ascertaining information about those who
had a fracture. In particular, it would be important to assess
whether the participant was wearing the hip protector at the
time of the fracture and the side on which the fracture oc-
curred. The data could then be analyzed either according to
the initial assignment of each hip to the intervention (which
would provide an estimate of effectiveness in the study
population), or by an analysis limited to those who were wear-
ing the hip protector when they had a fracture (which would
provide an estimate of efficacy when the hip protector is worn).
Both analyses would be based on samples of hips that were ran-
domized.
Peter Cummings, MD, MPH
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In Reply: In response to Drs Bulat and Quigley, the evidence
available at the time we initiated our study was considered
insufficient to establish the effectiveness of external hip pro-
tectors, and therefore the use of an usual care control group
was approved by the ethical review board of our hospital. Sev-
eral studies supporting the effectiveness of hip protectors were
published while we were collecting data. Most, however, were
small or used cluster randomization, which may compromise
validity.
Bulat and Quigley are concerned about our use of a calen-
dar to assess falls and fractures, and they raise the possibility
that the hip protectors may have lost effectiveness during the
12 months of our trial. The calendar was completed by a nurse
when the participant was cognitively impaired. Because this is
a prospective method, it is the most reliable method available.
According to the manufacturer of the hip protectors, the de-
vices may be used for about 1.5 years. The hip protectors were
checked during the unannounced visits, and the nurses con-
tacted us when they believed that the hip protectors should be
replaced.
We agree with Dr Honkanen that a 75% risk reduction is am-
bitious, but at the start of our trial we only had information
from a few trials suggesting that this was feasible. Despite this,
our study is still the largest randomized controlled trial that
uses individual randomization.
Like Bulat and Quigley, Honkanen is concerned about
our compliance rate. We have previously reported that com-
pliance rates are low in most studies,1 and that most studies
only report hip fractures in participants who were not com-
pliant. Thus, we cannot exclude poor compliance as a cause
for the lack of effectiveness of the hip protector in our study.
Hip protectors may be effective when compliance is
increased. We agree that future research should focus on
interventions to improve compliance and design of the hip
protector.
Compliance in our study was assessed by unannounced
visits. We believe this to be the most valid method. Other
studies did not actually check whether participants were
using hip protectors, but relied on diaries or telephone inter-
views. The diary method may give more complete informa-
tion, but recall bias and socially desirable answers may occur.
In addition to the unannounced visits, we did use the diary
method (calendar) and found a trend among participants who
fell frequently—those who reported greater compliance had
lower fracture rates than those who were less compliant, but
this method is less reliable and conclusions should not be
drawn from it.
Although type of institution can be an effect modifier in the
relationship between the use of hip protectors and hip frac-
tures, in our study this was not the case (P=.74 for interaction).
Therefore, analyses were not stratified.
We agree with Honkanen that it may be more difficult to get
the nursing staff committed to hip protectors when only a few
participants per ward are randomized. However, the compli-
ance during our unannounced visits was similar to the com-
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